Education
About Us
Working with TipRanks
Follow Us
NextCure Inc (NXTC)
NASDAQ:NXTC
Total Valuation
NextCure has a market cap or net worth of $59.21M. The enterprise value is -$16.89M.
Market Cap$59.21M
Enterprise Value-$16.89M
Share Statistics
NextCure has 5,203,299 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,203,299
Owned by Insiders―
Owned by Institutions24.12%
Financial Efficiency
NextCure’s return on equity (ROE) is -0.85 and return on invested capital (ROIC) is -82.89%.
Return on Equity (ROE)-0.85
Return on Assets (ROA)-0.69
Return on Invested Capital (ROIC)-82.89%
Return on Capital Employed (ROCE)-0.84
Revenue Per Employee0.00
Profits Per Employee-1.29M
Employee Count43
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NextCure is ―. NextCure’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio0.33
Price to Fair Value0.33
Price to FCF-0.52
Price to Operating Cash Flow-0.45
PEG Ratio0.03
Income Statement
In the last 12 months, NextCure had revenue of 0.00 and earned -55.65M in profits. Earnings per share was -23.88.
Revenue0.00
Gross Profit-2.87M
Operating Income-59.75M
Pretax Income-55.65M
Net Income-55.65M
EBITDA-54.34M
Earnings Per Share (EPS)-23.88
Cash Flow
In the last 12 months, operating cash flow was -48.94M and capital expenditures 34.00K, giving a free cash flow of -48.91M billion.
Operating Cash Flow-48.94M
Free Cash Flow-48.91M
Free Cash Flow per Share-9.40
Dividends & Yields
NextCure pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change-2.23%
50-Day Moving Average10.58
200-Day Moving Average6.83
Relative Strength Index (RSI)51.50
Average Volume (3m)37.58K
Important Dates
NextCure upcoming earnings date is Feb 26, 2026, TBA (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
NextCure as a current ratio of 7.50, with Debt / Equity ratio of 15.74%
Current Ratio7.50
Quick Ratio7.50
Debt to Market Cap0.00
Net Debt to EBITDA0.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NextCure has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NextCure EV to EBITDA ratio is <0.01, with an EV/FCF ratio of <0.01.
EV to Sales0.00
EV to EBITDA<0.01
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
NextCure has $29.11M in cash and marketable securities with $4.41M in debt, giving a net cash position of $24.70M billion.
Cash & Marketable Securities$29.11M
Total Debt$4.41M
Net Cash$24.70M
Net Cash Per Share$4.75
Tangible Book Value Per Share$28.09
Margins
Gross margin is -10.54%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-10.54%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NextCure is $17.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.67
Price Target Upside65.14% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast3.78%